Unveiling the best immune checkpoint inhibitor-based therapy for metastatic renal cell carcinoma in the first-line setting: an updated systematic review and Bayesian network analysis

Unveiling the best immune checkpoint inhibitor-based therapy for metastatic renal cell carcinoma in the first-line setting: an updated systematic review and Bayesian network analysis

Background: Immune checkpoint inhibitor (ICI)-based combination therapies have been recommended as first-line options for metastatic renal cell carcinoma (mRCC); however, no head-to-head randomized controlled trials (RCTs) have compared all existing ICI-based therapies. Objective: We aimed to analyz...

Full description

Saved in:
Bibliographic Details
Main Authors: Junpeng Wang, Xin Li, Mengjun Li, Qingyuan Liu, Zixuan Xie, Xiaotian Si, Lei Yang, Zhifeng Wang, Degang Ding
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359251353259
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items